Intersect ENT shares tumble on Q2 results

This article was originally published here

Shares in Intersect ENT (NSDQ:XENT) fell today after the medical device maker missed sales expectations on Wall Street with its second-quarter financial results.

The Menlo Park, Calif.-based company posted a net loss of -$4.2 million on sales of $26.3 million for the 3 months ended June 30, for sales growth of 9.7% compared with the same period last year.

Get the full story at our sister site, Drug Delivery Business News.

The post Intersect ENT shares tumble on Q2 results appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply